Evidence map›Paper›PMID 41754801›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

UHPLC-MS-Based Analysis of Fluvoxamine in Rabbit Aqueous Humour and Serum: Method Development and Validation.

Andrea Guba, Anna Takácsi-Nagy, Sourav Das, Bálint Szokol, Medveczki Timea, Márton Vajna, Gergő Kalló, Andrea Fekete, Judit Hodrea, Éva Csősz

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrea GubaProteomics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.ORCID 0009-0009-0535-2025
Anna Takácsi-NagyDepartment of Innovation, PannonPharma Ltd., PannonPharma út 1., 7720 Pécsvárad, Hungary.ORCID 0000-0002-4756-9136
Sourav DasNational Laboratory on Human Reproduction, University of Pécs Medical School, Vasvári Pál utca 4, 7622 Pécs, Hungary.ORCID 0000-0002-3753-9689
Bálint SzokolVichem Chemie Research Ltd., Viola utca 2., 8200 Veszprém, Hungary.ORCID 0000-0002-0196-6072
Medveczki TimeaMTA-SE Lendület "Momentum" Diabetes Research Group, Semmelweis University, Bókay János utca 54, 1083 Budapest, Hungary.ORCID 0000-0002-3618-6690
Márton VajnaUniversity Pharmacy-Department of Pharmacy Administration, Semmelweis University, Hőgyes Endre utca 7-9, 1092 Budapest, Hungary.
Gergő KallóProteomics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.ORCID 0000-0002-5732-8758
Andrea FeketeMTA-SE Lendület "Momentum" Diabetes Research Group, Semmelweis University, Bókay János utca 54, 1083 Budapest, Hungary.
Judit HodreaMTA-SE Lendület "Momentum" Diabetes Research Group, Semmelweis University, Bókay János utca 54, 1083 Budapest, Hungary.ORCID 0000-0002-6388-4021
Éva CsőszProteomics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.ORCID 0000-0003-4373-2175

Funding

MTA-SE "Lendület" LP2021-3/2021National Research, Development and Innovation STAGE 2024-1.2.3-HU-RIZONT-2024-00056National Research, Development and Innovation TKP2021-EGA-24
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aqueous humourEMA guidelinesfluvoxamineserumsigma-1 receptorUHPLC-MS method

Identifiers

PMID41754801
PMCPMC12943760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.